Obagi Eyes Future Under New Ownership

Tuesday, November 14, 2017 | Acquisitions and Mergers , Personnel/Company News , Skin Care , Obagi


The sale of Obagi Medical Products to the Haitong International Zhonghua Finance Acquisition Fund I, L.P. and limited partners China Regenerative Medicine International (CRMI) Ltd. is now complete.

The new Obagi organization will remain headquartered in Southern California. In a letter to customers announcing the sale, Jaime Castle President and General Manager, Obagi, said that under new ownership, “Obagi will renew its mission as a leading global physician-dispensed skin care company offering you the same high-quality Obagi products and high-level of customer service you have come to expect and deserve.”

Obagi products will continue to be distributed through McKesson Specialty. 

Next Story

Comments

You must be logged in to leave a comment.